Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis. (19th May 2021)

• Record Type: Journal Article
• Authors: Xiao, Junyan; Zhao, Chan; Liang, Anyi; Zhang, Meifen; Cheng, Gangwei
• Is Part Of: Ocular immunology and inflammation. Volume 29:Number 4(2021)
• Page Start: 766
• Page End: 770
• Publication Date: 2021-05-19
• Subjects: Uveitis -- steroid-induced glaucoma -- high-energy -- selective laser trabeculoplasty -- intraocular pressure; Eye -- Diseases -- Immunological aspects -- Periodicals; Eye -- Inflammation -- Periodicals; 617.7
• DOI: 10.1080/09273948.2019.1687730
• Languages: English
• ISSNs: 0927-3948

Abstract

ABSTRACT: Purpose : To assess the efficacy and safety of high-energy selective laser trabeculoplasty (SLT) for steroid-induced glaucoma in patients with quiescent uveitis. Methods : A retrospective study of steroid-induced glaucoma in quiescent uveitic patients who underwent SLT at our center from December 2014 to November 2017 and had been followed up for at least 1 year. Intraocular pressure (IOP) and IOP-lowering medications were recorded at baseline, and at 1 week, 1 month, 3 months, 6 months and 12 months after SLT. Treatment success was defined as IOP ≤18 mmHg and a ≥ 20% reduction in IOP without additional glaucoma surgery. Results : Twenty eyes from 19 patients were included. At the 12-month visit, mean IOP and mean number of IOP-lowering medications were significantly reduced as compared to baseline with an overall success rate of 65.0%. Conclusions : High-energy SLT appeared to be an effective and safe procedure for steroid-induced glaucoma with quiescent uveitis.